Association between FIB-4 index and lower extremity arterial disease in MASLD patients: a cross-sectional study
Chunxia Zhang,
No information about this author
Yuchen Ying,
No information about this author
Yuanhui Ru
No information about this author
et al.
Lipids in Health and Disease,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: March 20, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
associated
with
an
elevated
risk
of
cardiovascular
conditions,
such
as
lower
extremity
arterial
(LEAD).
The
Fibrosis-4
(FIB-4)
index,
a
non-invasive
marker
fibrosis,
may
have
predictive
value
for
LEAD
in
patients
MASLD.
This
study
aimed
to
explore
the
association
between
FIB-4
and
cohort
cross-sectional
included
481
participants
MASLD,
selected
from
comprehensive
health
check-up
database.
Participants
were
categorized
into
three
groups
based
on
their
index
(<
1.3,
1.3–2.66,
>
2.66)
underwent
duplex
ultrasonography
diagnose
LEAD.
Logistic
regression
models
employed
evaluate
LEAD,
adjusting
demographic,
metabolic,
lipid-related
factors.
Subgroup
analyses
performed
by
sex,
age,
diabetes
mellitus
status,
hypertension,
dyslipidemia,
smoking
status.
prevalence
increased
levels,
51.3%
low
group
86.5%
high
(p
<
0.001).
In
fully
adjusted
models,
higher
levels
significantly
(adjusted
odds
ratio
[OR]:
3.54,
95%
confidence
interval
[CI]:
1.39–9.01)
compared
group.
As
continuous
variable,
each
unit
increase
was
66%
likelihood
OR:
1.66,
CI:
1.12–2.26,
P
did
not
reveal
significant
interactions
(P
interaction
0.05).
Higher
are
independently
MASLD
patients,
although
subgroup
interactions.
suggests
that
further
studies
larger
sample
sizes
needed
these
relationships
more
comprehensively.
Language: Английский
miR-125b-5p regulates FFA-induced hepatic steatosis in L02 cells by targeting estrogen-related receptor alpha
Gao Fen,
No information about this author
Yanhua Ma,
No information about this author
Chun I. Yu
No information about this author
et al.
Gene,
Journal Year:
2025,
Volume and Issue:
unknown, P. 149419 - 149419
Published: March 1, 2025
Language: Английский
Cardiovascular-liver-metabolic health: Time to integrate liver assessment into cardiology practice?
Luan C V Lima,
No information about this author
Lubna Al‐Sharif,
No information about this author
Matheus Souza
No information about this author
et al.
Trends in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Animal Model Screening for Hyperlipidemic ICR Mice
Xingtong Chen,
No information about this author
Yunyue Zhou,
No information about this author
Jinbiao Yang
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 2142 - 2142
Published: Feb. 27, 2025
This
study
aimed
to
establish
a
hyperlipidemia
model
in
ICR
mice
using
homemade
high-fat
diet.
It
further
investigated
hyperlipidemia-related
indicators
control
and
at
various
feeding
durations
determine
the
optimal
time
frame
for
successful
establishment.
Sixteen
male
were
introduced
intervals
of
3
weeks,
starting
from
weeks
0,
3,
6,
9,
12.
The
group
was
fed
standard
diet,
while
received
diet
induce
hyperlipidemia.
Blood
lipid
related
indices
detected
15
weeks.
liver,
scapular
fat,
abdominal
epididymal
fat
harvested
calculate
organ
index.
contents
T-CHO,
TG,
TBA
liver
measured.
HE
staining
used
observe
pathological
changes
tissue
white
adipose
tissue,
Oil
Red
O
droplets
tissue.
mRNA
protein
expression
SREBP-2,
insig1,
HMGCR,
LXRα,
ABCA1,
CYP7A1
by
RT-qPCR
Western
Blot.
In
group,
blood
levels
significantly
increased
9th
week,
aligning
with
indicative
Insig-1,
markedly
elevated
9
remained
relatively
stable
thereafter.
provides
reliable
reference
determining
establishment
models
vivo
animal
experiments.
Language: Английский